Table 3.
Adverse outcomes
Variable | Intervention group | Control group | Difference (95% CI) | Odds ratio (95% CI) |
---|---|---|---|---|
Intention-to-treat analysis | ||||
No. of study participants | 398 | 402 | ||
ICU admission | 4 (1.0) | 6 (1.5) | –0.5 (–2.0 to 1.1) | 0.67 (0.19–2.39) |
Death during hospitalization | 2 (0.5) | 3 (0.8) | –0.2 (–1.3 to 0.9) | 0.67 (0.11–4.04) |
Readmission within 30 daysa | 23/392 (5.9) | 27/394 (6.9) | –1.0 (–4.4 to 2.4) | 0.85 (0.48–1.51) |
Death within 30 daysa | 3/392 (0.8) | 4/394 (1.0) | –0.3 (–1.6 to 1.1) | 0.75 (0.17–3.38) |
Per-protocol analysis | ||||
No. of study participants | 383 | 378 | ||
ICU admission | 4 (1.0) | 5 (1.3) | –0.3 (–1.8 to 1.3) | 0.79 (0.21–2.96) |
Death during hospitalization | 2 (0.5) | 3 (0.8) | –0.3 (– 1.4 to 0.9) | 0.66 (0.11–3.95) |
Readmission within 30 daysa | 22/377 (5.8) | 26/370 (7.0) | –1.2 (–4.7 to 2.3) | 0.82 (0.46–1.47) |
Death within 30 daysa | 3/377 (0.8) | 4/370 (1.1) | –0.3 (–1.7 to 1,1) | 0.73 (0.16–3.30) |
ICU, intensive care unit.
Data are presented as per cent for categorical variables. Difference between intervention and control group was compared using χ2 tests and logistic regression model was used to calculate unadjusted odds ratios.
The denominator is the number of study participants that were followed up at day 30.